Articles by Disease (Cerebellar Diseases)

Cytochrome P450 in the Brain ; A Review

Journal: Current Drug Metabolism
Volume: 2
Page: 245-263
Author(s): E. Hedlund, J. A. Gustafsson and M. Warner

The Hereditary Disease Array Group (HDAG) - Microarrays, Models and Mechanisms : A Collaboration Update

Journal: Current Genomics
Volume: 2
Page: 221-229
Author(s): Tim- Rasmus Kiehl, James M. Olson and Stefan M. Pulst

NMDA Receptor Pharmacology: Perspectives from Molecular Biology

Journal: Current Drug Targets
Volume: 2
Page: 215-231
Author(s): David R. Lynch and Rodney P. Guttmann

Ifenprodil, a Novel NMDA Receptor Antagonist : Site and Mechanism of Action

Journal: Current Drug Targets
Volume: 2
Page: 285-298
Author(s): Keith Williams

Convergence of PKC-Dependent Kinase Signal Cascades on NMDA Receptors

Journal: Current Drug Targets
Volume: 2
Page: 299-312
Author(s): J. F. Macdonald, S. A. Kotecha, W. Y. Lu and M. F. Jackson

The Use of Antibody Engineering to Create Novel Drugs that Target N-methyl-D-Aspartate Receptors

Journal: Current Drug Targets
Volume: 2
Page: 331-345
Author(s): Joseph R. Moskal, Hirotaka Yamamoto and Patricia A. Colley

Infective Proteins: The Prion Puzzle

Journal: Current Protein & Peptide Science
Volume: 2
Page: 191-204
Author(s): Fabrizio Ceciliani and Paola Pergami

Clinical Pharmacology of Serotonin Receptor Type 3 (5-HT3) Antagonists

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 1
Page: 171-199
Author(s): Zafar H. israili

Changes in Immune and Endocrine Systems in Scrapie-Infected Animals

Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 1
Page: 171-183
Author(s): X. Ye, A. C. Scallet and R. I. Carp

Rate Limiting Steps of AAV Transduction and Implications for Human Gene Therapy

Journal: Current Gene Therapy
Volume: 1
Page: 137-147
Author(s): S. Sanlioglu, M. M. Monick, G. Luleci, G. W. Hunninghake and J. F. Engelhardt